02/13/2025 18:13
Net Profit of Estithmar Holding Increases by 20% to QAR 422 Million, Revenues Rise by 44% to Reach QAR 4.2 Billion

Estithmar Holding Q.P.S.C. announced its financial results for the year ended December 31, 2024, reporting a 44% increase in revenues, reaching QAR 4.2 billion, compared to QAR 2.9 billion in 2023. The gross profits of the company reached QAR 1 billion, up from QAR 801 million in 2023, reflecting a 27% increase. The company also achieved earnings before interest, tax, depreciation, and amortization (EBITDA) of QAR 742 million. The results showed a 20% rise in the company’s net profit compared t...

02/13/2025 18:12
UAE Begins Mapping Air Corridors for Air Taxis and Cargo Drones to Transform Urban Transportation

The UAE has taken a bold step towards redefining urban transportation with the commencement of air corridor mapping and regulatory framework development for piloted and autonomous air taxis and cargo drones. This transformative initiative marks a major leap forward in the nation’s mission to lead the future of mobility. Through a strategic partnership between the General Civil Aviation Authority (GCAA) and the Advanced Technology Research Council (ATRC) entities—Technology Innovation Institute ...

02/13/2025 17:27
Sandvine Clears Major Milestones Enabling Close of Comprehensive Restructuring

Sandvine Corporation and certain of its affiliates and subsidiaries (“Sandvine” or the “Company”) today announced that on January 30, 2025, it received formal approval from the Ontario Superior Court of Justice (Commercial List) for its previously announced comprehensive restructuring, clearing the path to emerge from protection under the Companies’ Creditors Arrangement Act (“CCAA”) through a sale of its operations to a set of well-capitalized, newly formed entities. In addition, on February 1...

02/13/2025 18:30
City of Oulu: Finland’s Largest Hydrogen Refining Plant One Step Closer to Starting Sustainable Aviation Fuel Production

The City of Oulu, Finland, and French company Verso Energy have signed a co-operation agreement aiming to build a hydrogen processing plant in Oulu. Verso Energy intends to construct a plant with a yearly production capacity of 80 000 tonnes of e-SAF. The estimated value of the project is €1.4 billion, and it is expected to create 250 jobs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250213216649/en/The City of Oulu, Finland, and...

02/13/2025 18:00
Five-Time Olympic Medalist Gabby Thomas Joins Amazfit as Athlete Ambassador

Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), is proud to announce five-time Olympic Medalist and fashion icon, Gabby Thomas, as the latest ambassador to join the brand's growing roster of elite athletes. As part of the four-year partnership, Thomas will wear Amazfit smartwatches both on the track during training and in competition, and off the track to monitor sleep and recovery. Moreover, through the Zepp app-based food log, Gabby will have easy access to ...

02/14/2025 15:25
AESC Ranks Fourth in 2024 Global Energy Storage Cell Shipments According to InfoLink Consulting

AESC, a Japan-based global leader in high-performance battery technology, ranks among the top companies in global energy storage industry, according to the 2024 Non-China Markets’ Energy Storage Cell Shipment Ranking. The ranking by InfoLink Consulting, a leading research and consulting firm specializing in renewables and technology, covers utility-scale, commercial & industry, and residential applications. This achievement highlights AESC’s rapid expansion and continued leadership in the e...

02/14/2025 10:12
Kao Corporation Discloses the "Board of Directors' Opinion on Shareholder Proposal and Kao’s Strategy to Enhance Corporate Value"

Kao Corporation (TOKYO:4452) disclosed its opinion on February 14, 2025, regarding the shareholder proposals submitted by Oasis Japan Strategic Fund Ltd. (“Oasis”) for the 119th Annual General Meeting of Shareholders. Notice Regarding the Board of Directors' Opinion on a Shareholder Proposals Additionally, the company has published its response to a statement issued by Oasis in April 2024 in a document titled "Board of Directors' Opinion on Shareholder Proposal and Kao’s Strategy to Enhance C...

02/14/2025 17:33
Riskified To Report Fourth Quarter and Full-Year 2024 Financial Results on Wednesday, March 5

Riskified Ltd. (NYSE: RSKD), a leader in ecommerce fraud and risk intelligence, today announced it will release its fourth quarter and full-year 2024 financial results before the market opens on March 5, 2025. On that day management will host a conference call and webcast at 8:30 a.m. ET to discuss the company's business and financial results. Riskified Fourth Quarter and Full-Year 2024 Financial Results Conference Call When: Wednesday, March 5, 2025 Time: 8:30 a.m. ET Dial-in: To access th...

02/14/2025 19:17
Venture Global, Inc. Announces Timing of Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

Venture Global, Inc. (“Venture Global”) (NYSE: VG) announced today that it plans to issue its earnings release with respect to fourth quarter and full year 2024 financial results before market open on Thursday, March 6, 2025. Venture Global will host a conference call for investors and analysts beginning at 9:00 am Eastern Time (ET) on March 6, 2025, to discuss fourth quarter and full year results and provide guidance for the 2025 fiscal year. A listen-only webcast of the call and accompany...

02/15/2025 00:50
U.S. FDA Grants Full Approval of Deciphera’s ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase inhibitor, for adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity. The FDA previously granted Fast Track designation and Priority Review for ROMVIMZA, which was developed by Deciph...